Tilray Brands, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
TLRY on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
655 Madison Avenue, 19 Th Floor, New York, NY

Insiders trading volume in the past year

Tilray Brands, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brendan Kennedy Director $24.7M Nov 7, 2022
Irwin D. Simon President and CEO $11.1M +$100K +0.91% Jul 31, 2025
Denise M. Faltischek Chief Strategy Officer $2.39M Jul 31, 2025
Mitchell Gendel Global General Counsel $2.2M +$3.5K +0.16% Jul 31, 2025
Carl A. Merton Chief Financial Officer $1.67M +$55.3K +3.43% Jul 31, 2025
Thomas P. Looney Director $721K Jul 29, 2025
Jodi L. Butts Director $711K Jul 26, 2024
Hopkinson David G. Director $710K Jul 29, 2025
Johann Michael Herhalt Director $611K Jul 29, 2025
David Clanachan Director $609K Jul 29, 2025
Renah Persofsky Director $587K Jul 29, 2025
Michael Kruteck Chief Financial Officer $473K Apr 30, 2021
Jon Levin Chief Operating Officer $453K Apr 30, 2021
James R. Meiers Chief Operations Officer $324K Jun 1, 2022
Walter E. Robb IV Director $318K Jul 26, 2022
Steven M. Cohen Director Jul 29, 2025

Recent Insider Transactions by Companies or Individuals for Tilray Brands, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.